BOONE, N.C., Sept. 26, 2025 /PRNewswire/ — Fuse Oncology, a leader in AI-powered oncology workflow solutions, mission is to unify radiation oncology workflows through vendor-agnostic solutions that deliver real-world value. This vision will be on display at ASTRO, where GE HealthCare will feature Fuse solutions in its booth, underscoring the importance of collaboration and interoperability in advancing cancer care.
By seamlessly connecting across platforms, Fuse solutions are designed to improve efficiency, strengthen compliance, and reduce the administrative burden for care teams.
“Our goal is simple: eliminate unnecessary complexity in oncology workflows so that clinicians can spend more time with patients,” said James Bauler, CEO of Fuse Oncology. “By remaining vendor-agnostic, Fuse can deliver measurable improvements in efficiency, compliance, and revenue integrity across the entire ecosystem.”
Proven Impact Across Oncology Workflows
Fuse’s technology is already driving measurable results for cancer centers nationwide:
ASTRO attendees will experience firsthand how Fuse is redefining radiation oncology workflows with interoperable, vendor-agnostic solutions designed to streamline operations and free clinicians to focus on patient care.
About Fuse Oncology
Fuse Oncology is redefining cancer care with AI-powered, interoperable solutions built by industry insiders. Spun out of Cone Health in 2021 and powered by technology licensed from the University of Michigan, Fuse is realizing a bold vision: an end-to-end oncology workflow that enables providers to move at the speed of the patient™. From charge capture and documentation to clinical insights and analytics, Fuse helps oncology practices streamline operations, reduce burnout, and recover missed charges so clinicians can focus on patients, not paperwork.
SOURCE Fuse Oncology, Inc.
KANAZAWA, Japan, Dec. 26, 2025 /PRNewswire/ -- Scientists at the Nano Life Science Institute (WPI-NanoLSI), Kanazawa…
LOS ANGELES, Dec. 25, 2025 /PRNewswire/ -- From January 6–9, 2026, visitors can experience Arspura's…
RAMAT GAN, ISRAEL, Dec. 24, 2025 (GLOBE NEWSWIRE) -- XTL Biopharmaceuticals Ltd. (Nasdaq:XTLB) (TASE:XTLB.TA) (the…
A summary of the current discussions in consumer health and wellness on the topic of…
LAS VEGAS, Dec. 24, 2025 (GLOBE NEWSWIRE) -- This holiday season, addiction experts at Desert Hope…
TORONTO, Dec. 24, 2025 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the…